Slim Fourati
Impact in
- Infectious Diseases top 1%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- HIV/AIDS drug development and treatment
- Viral Infections and Vectors
- SARS-CoV-2 detection and testing
- Virology top 2%
- HIV Research and Treatment
Papers in
-
- SARS-CoV-2 and COVID-19 Research 39
- HIV/AIDS drug development and treatment 23
- COVID-19 Clinical Research Studies 21
- Epidemiology 37
- Respiratory viral infections research 14
- Hepatitis B Virus Studies 9
- Co-authors
- Armand Mekontso Dessap (14 shared papers)Jean–Michel Pawlotsky (33 shared papers)Guillaume Carteaux (6 shared papers)Nicolas de Prost (21 shared papers)Anne‐Geneviève Marcelin (22 shared papers)Christine Katlama (17 shared papers)Sébastien Maury (7 shared papers)Christian Brun‐Buisson (2 shared papers)
- Journals
- Journal of Antimicrobial Chemotherapy (11 papers)Clinical Infectious Diseases (7 papers)Antimicrobial Agents and Chemotherapy (5 papers)AIDS (5 papers)The Journal of Infectious Diseases (5 papers)
- Partner nations
- FranceUnited StatesItaly
In The Last Decade
Slim Fourati
131 papers receiving 3.5k citations
Slim Fourati's Hit Papers
Peers
Comparison fields: 5 of 115
- Infectious Diseases 2.0k
- Virology 404
- Hepatology 311
- Epidemiology 673
- Immunology 390
Countries citing papers authored by Slim Fourati
This map shows the geographic impact of Slim Fourati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Slim Fourati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Slim Fourati more than expected).
Fields of papers citing papers by Slim Fourati
This network shows the impact of papers produced by Slim Fourati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Slim Fourati. The network helps show where Slim Fourati may publish in the future.
Co-authors
The 25 scholars most cited alongside Slim Fourati, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 140 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Zika Virus Associated with Meningoencephalitis Hit paper breakdown → | 2016 | 396 |
| 2 | 2021 | 249 | |
| 3 | 2020 | 159 | |
| 4 | 2020 | 139 | |
| 5 | 2021 | 107 | |
| 6 | 2020 | 98 | |
| 7 | 2021 | 95 | |
| 8 | 2020 | 90 | |
| 9 | 2018 | 72 | |
| 10 | 2021 | 67 | |
| 11 | 2021 | 64 | |
| 12 | 2020 | 64 | |
| 13 | 2020 | 58 | |
| 14 | 2021 | 58 | |
| 15 | 2013 | 56 | |
| 16 | 2018 | 55 | |
| 17 | 2010 | 53 | |
| 18 | 2014 | 50 | |
| 19 | 2015 | 48 | |
| 20 | 2022 | 48 |
About Slim Fourati
Slim Fourati is a scholar working on Infectious Diseases, Epidemiology, Hepatology, Virology and Neurology, having authored 140 papers that have together received 3.5k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (39 papers), HIV/AIDS drug development and treatment (23 papers), COVID-19 Clinical Research Studies (21 papers), Respiratory viral infections research (14 papers), Hepatitis C virus research (14 papers), HIV Research and Treatment (11 papers), Long-Term Effects of COVID-19 (11 papers) and Hepatitis B Virus Studies (9 papers). The work is most often cited by research in Infectious Diseases (2.0k citations), Virology (404 citations), Hepatology (311 citations), Epidemiology (673 citations) and Immunology (390 citations). Slim Fourati has collaborated with scholars based in France, United States and Italy. Frequent co-authors include Armand Mekontso Dessap, Jean–Michel Pawlotsky, Guillaume Carteaux, Nicolas de Prost, Anne‐Geneviève Marcelin, Christine Katlama, Sébastien Maury, Christian Brun‐Buisson, Damien Contou and Christophe Rodriguez. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, Clinical Infectious Diseases, Antimicrobial Agents and Chemotherapy, AIDS and The Journal of Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.